Adenoviral overexpression of interleukin-1 receptor antagonist protein increases β-cell replication in rat pancreatic islets

Gene Therapy

Volumn 12, Issue 2, 2005, Pages 120-128

  Tellez N ^a   Montolio, M ^a   Biarnes M ^a   Castanno E ^b   Soler, J ^a   Montanya, E ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

cell replication; Ad IL 1Ra; Diabetes; IL 1 ; IRAP

Indexed keywords

ADENOVIRUS VECTOR; GLUCOSE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL BASED GENE THERAPY; CELL DIVISION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; FLOW CYTOMETRY; GENE OVEREXPRESSION; MALE; NICK END LABELING; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STREPTOZOCIN DIABETES; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; DIABETES MELLITUS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; INSULIN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICROSCOPY, FLUORESCENCE; RATS; RATS, INBRED LEW; SIALOGLYCOPROTEINS; TRANSFECTION;

EID: 13244278034     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302351     Document Type: Article

References (45)

1. Bonner-Weir S. Perspective: postnatal pancreatic β cell growth. Endocrinology 2000; 141: 1926-1929.
2. Montanya E, Nacher V, Biarnés M, Soler J. Linear correlation between β-cell mass and body weight throughout the lifespan in Lewis rats. Diabetes 2000; 49: 1341-1346.
3. Sorenson RL, Brelje TC. Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 1997; 29: 301-307.
4. Bonner-Weir S, Deery D, Leahy JL, Weir GC. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes 1989; 38: 49-53.
5. Brockenbrough JS, Weir GC, Bonner-Weir S. Discordance of exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes 1988; 37: 232-236.
6. Liu YQ, Montanya E, Leahy JL. Increased islet DNA synthesis and glucose-derived lipid and aminoacid production in association with beta-cell hyperproliferation in normoglycemic 60% pancreatectomy rats. Diabetologia 2001; 44: 1026-1033.
7. Nacher V et al. β-Cell growth and mass are preserved in long-term syngeneic islet transplantation in streptozotocin-induced diabetic Lewis Rats. Diabetes 1996; 45: 1541-1546.
8. Eizirik DL, Mandrup-Poulsen T. A choice of death. The signal transduction of immune-mediated β-cell apoptosis. Diabetologia 2001; 44: 2115-2133.
9. Mathis D, Vence L, Benoist C. β-Cell death during progression to diabetes. Nature 2001; 414: 792-798.
10. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of insulin-dependent diabetes mellitus. Diabetologia 1996; 39: 1005-1029.
11. Eizirik DL. Interleukin-1β induces an early decrease in insulin release, (pro)insulin biosynthesis and insulin mRNA in mouse pancreatic islets by a mechanism dependent on gene transcription and protein synthesis. Autoimmunity 1991; 10: 107-113.
12. Sandler S, Andersson A, Hellerstrom C. Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets. Endocrinology 1987; 121: 1424-1431.
13. Giannoukakis N, Rudert WA, Trucco M, Robbins PD. Protection of human islets from the effects of interleukin-1β by adenoviral gene transfer of an IκB repressor. J Biol Chem 2000; 275: 36509-36513.
14. Rabinovitch A et al. DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 1994; 37: 733-738.
15. Delaney CA et al. Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 1997; 138: 2610-2614.
16. Stassi G et al. Nitric oxide primes pancreatic beta cells for Fas-mediated destruction in insulin-dependent diabetes mellitus. J Exp Med 1997; 186: 1193-1200.
17. Sjöholm Å. Inhibition of fetal rat pancreatic β-cell replication by interleukin-1β in vitro is not mediated through pertussis toxin-sensitive G-proteins, a decrease in cyclic AMP, or protease activation. FEBS Lett 1991; 289: 249-252.
18. Eizirik DL et al. Interleukin-1β depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. Endocrinology 1990; 127: 2290-2297.
19. Southern C, Schulster D, Green IC. Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1. Biochem J 1990; 272: 243-245.
20. Maedler K et al. Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 2001; 50: 1683-1690.
21. Scarim AL et al. Evidence for the presence of type I IL-1 receptors on β-cells of islets of Langerhans. Biochim Biophys Acta 1997; 1361: 313-320.
22. Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991; 266: 10331-10336.
23. Giannoukakis N et al. Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1β-induced β-cell impairment and activation of islet cell apoptosis in vitro. Diabetes 1999; 48: 1730-1736.
24. Sandberg JO, Eizirik DL, Sandler S. IL-1 receptor antagonist inhibits recurrence of disease after syngeneic pancreatic islet transplantation to spontaneously diabetic non-obese (NOD) mice. Clin Exp Immunol 1997; 108: 314-317.
25. Sandler S et al. Decreased cell replication and polyamine content in insulin-producing cells after exposure to human interleukin 1 beta. Immunol Lett 1989; 22: 267-272.
26. Sjöholm Å. Cytokines inhibit proliferation and insulin secretion by rat insulinoma cells (RINm5F) non-synergistically and in a pertussis toxin-insensitive manner. Immunol Lett 1991; 30: 81-86.
27. Sjoholm A. Differential effects of cytokines on long-term mitogenic and secretory responses of fetal rat pancreatic beta cells. Am J Cell Physiol 1992; 263: 114-120.
28. Eizirik DL et al. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 1994; 93: 1968-1974.
29. Vargas F et al. Endotoxin contamination may be responsible for the unexplained failure of human pancreatic islet transplantation. Transplantation 1998; 65: 722-727.
30. Berney T et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001; 71: 125-132.
31. Ozasa T et al. Cytokine gene expression in pancreatic islet grafts in the rat. Transplantation 1997; 64: 1152-1159.
32. Hoorens A, Stangé G, Pavlovic D, Pipeleers D. Distinction between interleukin-1-induced necrosis and apoptosis of islet cells. Diabetes 2001; 50: 551-557.
33. Donath MY, Gross DJ, Cerasi E, Kaiser N. Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 1999; 48: 738-744.
34. Hoorens A, Van de Casteele M, Kloppel G, Pipeleers D. Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program. J Clin Invest 1996; 98: 1568-1574.
35. Eizirik DL, Darville MI. Beta-cell apoptosis and defense mechanisms: lessons from type 1 diabetes. Diabetes 2001; 50 (Suppl 1): S64-S69.
36. Kloppel G et al. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985; 4: 110-125.
37. Butler AE et al. β-Cell deficit and increased beta cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52 102-110.
38. Swenne I. Pancreatic β-cell growth and diabetes mellitus. Diabetologia 1992; 35: 193-201.
39. Sjoholm A. Diabetes mellitus and impaired pancreatic β-cell proliferation. J Int Med 1996; 239: 211-220.
40. Zhu M et al. Poor capacity for proliferation of pancreatic β-cells in Otsuka-Long-Evans-Tokushima Fatty rat. A model of spontaneous NIDDM. Diabetes 1996; 45: 941-946.
41. Movassat J, Saulnier C, Portha B. Insulin administration enhances growth of the β-cell mass in streptozotocin-treated newborn rats. Diabetes 1997; 46: 1445-1452.
42. Maedler K et al. Glucose-induced beta cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 2002; 110: 851-860.
43. Persidsky MD, Baillie GS. Fluorometric test of cell membrane integrity. Cryobiology 1977; 14: 322-331.
44. Biarnes M et al. β-Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycaemia. Diabetes 2002; 51: 66-72.
45. Giulietti A et al. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25: 386-401.